Treatment of UTIs Due to <i>Klebsiella pneumoniae</i> Carbapenemase-Producers: How to Use New Antibiotic Drugs? A Narrative Review
Background: <i>K. pneumoniae</i> is one of the bacteria most frequently causing health care-associated urinary tract infections, and increasingly incriminating <i>Klebsiella pneumoniae</i> carbapenemase producers (KPCp). Most infections caused by KPCp are nosocomial and might...
Guardado en:
Autores principales: | Caroline Chapelle, Benjamin Gaborit, Raphaëlle Dumont, Aurélien Dinh, Maxime Vallée |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3d2cef3ac8a4b338454bfe53c7582b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
por: Helio S. Sader, et al.
Publicado: (2021) -
<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
por: Melissa D. Barnes, et al.
Publicado: (2017) -
A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Strain Harboring <italic toggle="yes">bla</italic><sub>KPC-14</sub> Isolated in New York City
por: Siqiang Niu, et al.
Publicado: (2020) -
Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient
por: Paolo Gaibani, et al.
Publicado: (2021) -
Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> subsp. <i>pneumoniae</i> Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
por: Carla Fontana, et al.
Publicado: (2021)